no icon
no icon
amc icon

Uti Healthcare Fund - Direct Growth Plan

Equity | Sector Specific - Pharma

(NAV as of 16/04/2024)
246.77 (0.43)

3Y Returns

15.43%

Min SIP

500

Min Lumpsum

5000

Expense Ratio

1.36%

Fund Size

870 Cr

Inception Date

01-Jan-13

Fund Manager

Kamal Gada

Exit Load

1% on or before 30D, Nil after 30D.

Wealthzi View

Market Risk / Risk Taken Compared to Benchmark

Fund Size

SIP Returns

Risk Adjusted Returns

Extra Returns Over Benchmark

Returns Consistency

Performance Against Inflation

Overall Fund Zi Tag

Asset Allocation

Equity

98.50%

Debt & Others

1.50%

Market Cap Allocation

Large Cap

41.33%

Mid Cap

28.69%

Small Cap

28.48%

Other Cap

1.50%

Sector Allocation

Pharmaceuticals

75.13%

Health Care

22.58%

Cash/Deposits/Margins/Treps/Repo/Swaps

1.52%

Insurance

0.63%

Govt-Sec

0.14%

Top Ten Holdings

Sun Pharmaceutical Industries Ltd

12.96%

Cipla Ltd

7.35%

Apollo Hospitals Enterprises Ltd

7.12%

Dr. Reddy'S Laboratories Ltd

6.57%

Ajanta Pharma Ltd

4.97%

Investment Objective

The Primary Objective Of The Scheme Is To Generate Long Term Capital Appreciation By Investing Predominantly In Equity And Equity Related Securities Of Companies/Institutions Engaged In The Healthcare Services Sector. However, There Can Be No Assurance Or Guarantee That The Investment Objective Of The Scheme Would Be Achieved.

Fund House Detail

AMC Name

UTI Asset Management Company Private Limited

Address

UTI Towers, Gn BlockBandra Kurla Complex, Bandra (East)Mumbai - 400 051

BUILD WEALTH WITH CONFIDENCE

no iconno iconno iconno icon
no icon

BSE Member code: 58371

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
get on play storeget on app store

Wealthzi Investment Advisers (A division of Lime Internet Private Limited)

[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]

[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sahad PV, Email: [email protected]]

[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]

Disclaimers:

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The information is only for consumption by the client and such material should not be redistributed.